Dengue vaccine - International Vaccine InstituteAlternative Names: Dengue virus vaccine - International Vaccine Initiative
Latest Information Update: 31 Aug 2006
At a glance
- Originator International Vaccine Institute
- Class Dengue vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Dengue
Most Recent Events
- 31 Aug 2006 This programme is still in active development
- 15 Sep 2003 Preclinical trials in Dengue in South Korea (unspecified route)